Botanical species · safety record

Aristolochia debilis

The EFSA Compendium of Botanicals holds 20 constituent measurements, 2 adverse-effect records and 1 genotoxicity assay for Aristolochia debilis. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Aristolochia debilis Siebold & Zucc.

20Constituent measurements
3Safety records
6Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Aristolochia11
  • Aristolactam6
  • Fangchinoline1
  • Magnoflorine1
  • Tetrandrine1

Plant parts

  • Fruit peel12
  • Unspecified4
  • Roots and other underground parts3
  • Fruit unspecified1

Preparations

  • Solvent extraction21

Effect types

  • Nephrotoxicity2

Target tissues

  • Urogenital: kidneys2

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AristolactamUnspecifiedSolvent extraction0.285 Milligram/gramHPLC-DADResolve DOI
AristolactamFruit peelSolvent extraction≤ 0.509 Milligram/gramHPLC-DADResolve DOI
AristolactamFruit peelSolvent extraction≥ 0.027 Milligram/gramHPLC-DADResolve DOI
AristolactamFruit peelSolvent extraction≤ 0.046 Milligram/gramHPLC-DADResolve DOI
AristolactamFruit peelSolvent extraction≥ 0.017 Milligram/gramHPLC-DADResolve DOI
AristolactamUnspecifiedSolvent extractionHPLC-MS/MSResolve DOI
AristolochiaUnspecifiedSolvent extractionHPLC-MS/MSResolve DOI
AristolochiaFruit unspecifiedResolve DOI
AristolochiaFruit peelSolvent extraction≤ 0.872 Milligram/gramHPLC-DADResolve DOI
AristolochiaFruit peelSolvent extraction≥ 0.382 Milligram/gramHPLC-DADResolve DOI
AristolochiaFruit peelSolvent extraction≤ 1.179 Milligram/gramHPLC-DADResolve DOI
AristolochiaFruit peelSolvent extraction≥ 0.369 Milligram/gramHPLC-DADResolve DOI
AristolochiaFruit peelSolvent extraction≤ 0.524 Milligram/gramHPLC-DADResolve DOI
AristolochiaFruit peelSolvent extraction≥ 0.064 Milligram/gramHPLC-DADResolve DOI
AristolochiaFruit peelSolvent extraction≤ 1.41 Milligram/gramHPLC-DADResolve DOI
AristolochiaFruit peelSolvent extraction≥ 0.299 Milligram/gramHPLC-DADResolve DOI
AristolochiaUnspecifiedSolvent extraction4.265 Milligram/gramHPLC-DADResolve DOI
FangchinolineRoots and other underground partsSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
MagnoflorineRoots and other underground partsSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
TetrandrineRoots and other underground partsSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
NephrotoxicityUrogenital: kidneysSolvent extractionRat (as animal)SubchronicNo resolvable identifier
NephrotoxicityUrogenital: kidneysSolvent extractionRat (as animal)SubchronicNo resolvable identifier

Genotoxicity testing

Outcomes of genotoxicity assays as recorded in the source. A negative assay is a result under those test conditions, not a clearance.

OutcomeEndpointTestTested organismMetabolic activationSource
Positivebacterial reverse mutation assayBacteria (as organism)Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Song, Li-Qun., Ma, Xiao-Peng., Wang, Li-Zhe., Qiao, Yu., Song, Ye-Xu., Ma, Yan-Chun. The water decoction of Aristolochia debilis Sieb.et Zucc induces renal toxic effects in rats . African journal of pharmacy and pharmacology, 2010, vol. 4, no. 1, p. 8-12.
  2. Zhou, J., Ouedraogo, M., Qu, F., Duez, P. Potential genotoxicity of traditional Chinese medicinal plants and phytochemicals: An overview. Phytotherapy Research, 2013, vol. 27, no. 12, p. 1745-1755. DOI
  3. Yuan, Jinbin., Liu, Qian., Zhu, Weifeng., Ding, Li., Tang, Fei., Yao, Shouzhuo. Simultaneous analysis of six aristolochic acids and five aristolactams in herbal plants and their preparations by high-performance liquid chromatography-diode array detection-fluorescence detection . Journal of chromatography a, 2008, vol. 1182, no. 1, p. 85-92. DOI
  4. Xu, Yu-Qiong., Li, Xiao-Wei., Liu, Guang-Xue., Wang, Xuan., Shang, Ming-Ying., Li, Xiao-Mei., Cai, Shao-Qing. Comparative study of the contents of analogues of aristolochic acid in two kinds of Aristolochiae Fructus by high-performance liquid chromatography . Journal of natural medicines, 2013, vol. 67, no. 1, p. 113-122. DOI
  5. Kong, D., Gao, H., Li, X., Lu, J., Yuan, D. Rapid determination of eight aristolochic acid analogues in five Aristolochiaceae plants by ultra-high performance liquid chromatography quadrupole/time-of-flight mass spectrometry. Journal of chinese pharmaceutical sciences, 2015, vol. 24, no. 6, p. 364-375. DOI
  6. Ruecker, G., Mayer, R. Bisbenzylisoquinoline alkaloids from roots of Aristolochia debilis. Planta medica, 1985, vol. (2), p. 183-4.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue